DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+17.89%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$2.61B
AUM Growth
+$2.61B
(+6%)
Cap. Flow
-$175M
Cap. Flow
% of AUM
-6.73%
Top 10 Holdings %
Top 10 Hldgs %
41.68%
Holding
110
New
10
Increased
19
Reduced
25
Closed
16
Top Buys
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$37.7M |
| 2 |
Alector
ALEC
|
$36.6M |
| 3 |
Axogen
AXGN
|
$35M |
| 4 |
PTLA
Portola Pharmaceuticals, Inc.
PTLA
|
$32.6M |
| 5 |
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
|
$27.3M |
Top Sells
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
$45.6M |
| 2 |
Ascendis Pharma
ASND
|
$42.5M |
| 3 |
eHealth
EHTH
|
$39.7M |
| 4 |
Vericel Corp
VCEL
|
$35.7M |
| 5 |
Tandem Diabetes Care
TNDM
|
$32.9M |
Sector Composition
| 1 | Healthcare | 68.74% |
| 2 | Financials | 1.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Vericel Corp
VCEL
$1.69B
| $29.6M | 1.13% |
1,689,000
-2,036,900
| -55% | -$35.7M |
|
27
Select Medical
SEM
$1.6B
| $28.8M | 1.1% |
3,792,786
+1,226,142
| +48% | +$9.31M |
|
28
Editas Medicine
EDIT
$225M
| $28.3M | 1.09% |
1,158,841
| – | – |
|
|
29
eHealth
EHTH
$126M
| $27.4M | 1.05% |
439,609
-636,793
| -59% | -$39.7M |
|
30
Natera
NTRA
$23B
| $27.3M | 1.05% |
1,322,834
+69,834
| +6% | +$1.44M |
|
|
DFBHU
31
DELISTED
DFB Healthcare Acquisitions Corp. Unit
DFBHU
| $25.4M | 0.97% |
2,500,000
| – | – |
|
32
Kiniksa Pharmaceuticals
KNSA
$2.63B
| $23.7M | 0.91% |
1,310,259
+181,437
| +16% | +$3.28M |
|
33
Xeris Biopharma Holdings
XERS
$1.27B
| $23.6M | 0.91% |
2,355,136
-143,530
| -6% | -$1.44M |
|
|
SIEN
34
DELISTED
Sientra, Inc.
SIEN
| $23.4M | 0.9% |
273,063
+115,774
| +74% | +$9.93M |
|
35
Galapagos
GLPG
$2.06B
| $20.8M | 0.8% |
176,958
-111,449
| -39% | -$13.1M |
|
|
BOLD
36
DELISTED
Audentes Therapeutics, Inc
BOLD
| $19.3M | 0.74% |
493,901
| – | – |
|
37
KalVista Pharmaceuticals
KALV
$713M
| $18.6M | 0.71% |
650,000
| – | – |
|
|
MRTX
38
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $18.5M | 0.71% |
252,200
-622,286
| -71% | -$45.6M |
|
39
Glaukos
GKOS
$5.42B
| $17.9M | 0.68% |
227,762
-276,238
| -55% | -$21.6M |
|
|
40
Ascendis Pharma
ASND
$12.1B
| $17M | 0.65% |
144,194
-360,904
| -71% | -$42.5M |
|
41
Addus HomeCare
ADUS
$2.08B
| $16.1M | 0.62% |
252,915
+20,015
| +9% | +$1.27M |
|
42
Universal Health Services
UHS
$11.6B
| $15.9M | 0.61% |
119,000
-213,000
| -64% | -$28.5M |
|
43
Wave Life Sciences
WVE
$1.27B
| $15.3M | 0.59% |
+394,737
| New | +$15.3M |
|
44
Elevance Health
ELV
$72.4B
| $15.2M | 0.58% |
53,000
-42,000
| -44% | -$12.1M |
|
|
DCPH
45
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $14.1M | 0.54% |
607,633
| – | – |
|
|
MOR
46
DELISTED
MorphoSys AG American Depositary Shares
MOR
| $13.6M | 0.52% |
600,000
| – | – |
|
47
Arvinas
ARVN
$580M
| $13.6M | 0.52% |
921,234
| – | – |
|
|
DBVT
48
DBV Technologies
DBVT
$249M
| $13.1M | 0.5% |
+170,122
| New | +$13.1M |
|
49
Molina Healthcare
MOH
$9.6B
| $12.2M | 0.47% |
86,000
-65,772
| -43% | -$9.34M |
|
|
SYRS
50
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $11.6M | 0.44% |
126,895
| – | – |
|